Adamas scores orphan approval for tweaked generic Parkinson's med

25th August 2017 Uncategorised 0

Adamas may be the first company to have won FDA approval for a medication to treat dyskinesia in Parkinson’s patients. But that doesn’t mean it will be the first company to use that med to treat the condition.

More: Adamas scores orphan approval for tweaked generic Parkinson's med
Source: fierce